GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » IDT Australia Ltd (ASX:IDT) » Definitions » 10-Year ROIIC %

IDT Australia (ASX:IDT) 10-Year ROIIC % : 1.86% (As of Jun. 2024)


View and export this data going back to 1991. Start your Free Trial

What is IDT Australia 10-Year ROIIC %?

10-Year Return on Invested Incremental Capital (10-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 10-year. IDT Australia's 10-Year ROIIC % for the quarter that ended in Jun. 2024 was 1.86%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for IDT Australia's 10-Year ROIIC % or its related term are showing as below:

ASX:IDT's 10-Year ROIIC % is ranked worse than
54.72% of 932 companies
in the Drug Manufacturers industry
Industry Median: 3.685 vs ASX:IDT: 1.86

IDT Australia 10-Year ROIIC % Historical Data

The historical data trend for IDT Australia's 10-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IDT Australia 10-Year ROIIC % Chart

IDT Australia Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
10-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.05 -8.04 -6.76 59.82 1.86

IDT Australia Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
10-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.76 - 59.82 - 1.86

Competitive Comparison of IDT Australia's 10-Year ROIIC %

For the Drug Manufacturers - Specialty & Generic subindustry, IDT Australia's 10-Year ROIIC %, along with its competitors' market caps and 10-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IDT Australia's 10-Year ROIIC % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, IDT Australia's 10-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where IDT Australia's 10-Year ROIIC % falls into.



IDT Australia 10-Year ROIIC % Calculation

IDT Australia's 10-Year ROIIC % for the quarter that ended in Jun. 2024 is calculated as:

10-Year ROIIC %=10-Year Incremental Net Operating Profit After Taxes (NOPAT)**/10-Year Incremental Invested Capital**
=( -6.104241 (Jun. 2024) - -6.173871 (Jun. 2014) )/( 28.184 (Jun. 2024) - 24.448 (Jun. 2014) )
=0.06963/3.736
=1.86%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 10-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


IDT Australia  (ASX:IDT) 10-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


IDT Australia 10-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of IDT Australia's 10-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


IDT Australia Business Description

Traded in Other Exchanges
N/A
Address
45 Wadhurst Drive, Boronia, Melbourne, VIC, AUS, 3155
IDT Australia Ltd produces, develops, and supplies pharmaceutical products. It is engaged in the provision of research and development and other technical services for the pharmaceutical and allied industries. The company is involved in the manufacture of Active Pharmaceutical Ingredients (API) and Finished Dose Forms (FDF), microbiological and analytical testing, clinical packaging, and pharmacy services.

IDT Australia Headlines

From GuruFocus

Q1 2024 IDT Corp Earnings Call Transcript

By GuruFocus Research 02-10-2024

Q3 2023 IDT Corp Earnings Call Transcript

By GuruFocus Research 02-10-2024

Q2 2024 IDT Corp Earnings Call Transcript

By GuruFocus Research 03-07-2024

Q1 2025 IDT Corp Earnings Call Transcript

By GuruFocus News 12-05-2024

Q4 2022 IDT Corp Earnings Call Transcript

By GuruFocus Research 02-10-2024